![Zhen Pan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Zhen Pan
Direttore/Membro del Consiglio presso SHANGHAI GUIJIU CO.,LTD
Posizioni attive di Zhen Pan
Società | Posizione | Inizio | Fine |
---|---|---|---|
SHANGHAI GUIJIU CO.,LTD | Direttore/Membro del Consiglio | 01/09/2021 | - |
Hebei Yipin Pharmaceutical Co., Ltd.
![]() Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Direttore/Membro del Consiglio | 01/03/2021 | - |
Storia della carriera di Zhen Pan
Formazione di Zhen Pan
Shanghai Jiao Tong University | Masters Business Admin |
Shanghai University of Finance & Economics | Undergraduate Degree |
Statistiche
Distribuzione geografica
Cina | 5 |
Posizioni
Director/Board Member | 2 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Settori
Consumer Services | 3 |
Consumer Non-Durables | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
SHANGHAI GUIJIU CO.,LTD | Consumer Non-Durables |
Aziende private | 1 |
---|---|
Hebei Yipin Pharmaceutical Co., Ltd.
![]() Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Health Technology |
- Borsa valori
- Insiders
- Zhen Pan
- Esperienza